Search results for "Methicillin-Resistant Staphylococcus aureu"

showing 10 items of 49 documents

Staphylococcus aureus résistant à la méthicilline chez des mères et des enfants hospitalisés à Alger : prédominance du clone virulent européen

2014

NON DISPONIBILE

Settore MED/07 - Microbiologia E Microbiologia ClinicaClone ST80business.industryClone (cell biology)Leucocidine de Panton-Valentine; SARM; Clone ST80VirulenceSARMmedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataMethicillin-resistant Staphylococcus aureusMicrobiologyInfectious DiseasesmedicineMRSA ST80 mothers children AlgiersbusinessLeucocidine de Panton-Valentine
researchProduct

Auranofin and related heterometallic gold(I)-thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains.

2014

A series of new heterometallic gold(I) thiolates containing ferrocenyl-phoshines were synthesized. Their antimicrobial properties were studied and compared to that of FDA-approved drug, auranofin (Ridaura), prescribed for the treatment of rheumatoid arthritis. MIC in the order of one digit micromolar were found for most of the compounds against Gram-positive bacteria Staphylococcus aureus and CA MRSA strains US300 and US400. Remarkably, auranofin inhibited S. aureus, US300 and US400 in the order of 150-300 nM. This is the first time that the potent inhibitory effect of auranofin on MRSA strains has been described. The effects of a selected heterometallic compound and auranofin were also stu…

Methicillin-Resistant Staphylococcus aureusStaphylococcus aureusAuranofinMicrobial Sensitivity Testsmedicine.disease_causeCrystallography X-RayBiochemistryArticleMicrobiologyInorganic ChemistryAuranofinmedicineHumansInhibitory effectbiologyChemistryAntimicrobialbiology.organism_classificationMethicillin-resistant Staphylococcus aureusKidney cellAnti-Bacterial AgentsHEK293 CellsStaphylococcus aureusOrganogold CompoundsBacteriamedicine.drugJournal of inorganic biochemistry
researchProduct

Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature

2015

AbstractNeutrophil extracellular traps (NETs) composed of DNA decorated with histones and proteases trap and kill bacteria but also injure host tissue. Here we show that during a bloodstream infection with methicillin-resistant Staphylococcus aureus, the majority of bacteria are sequestered immediately by hepatic Kupffer cells, resulting in transient increases in liver enzymes, focal ischaemic areas and a robust neutrophil infiltration into the liver. The neutrophils release NETs into the liver vasculature, which remain anchored to the vascular wall via von Willebrand factor and reveal significant neutrophil elastase (NE) proteolytic activity. Importantly, DNase although very effective at D…

MaleMethicillin-Resistant Staphylococcus aureusExtracellular TrapsProteasesHydrolasesKupffer CellsGeneral Physics and AstronomyBacteremiaBiologyHepatic Veinsmedicine.disease_causeExtracellular TrapsGeneral Biochemistry Genetics and Molecular BiologyHistonesMiceHepatic ArteryVon Willebrand factorProtein-Arginine Deiminase Type 4von Willebrand FactormedicineAnimalsMice KnockoutMultidisciplinaryDeoxyribonucleasesGeneral ChemistryNeutrophil extracellular trapsStaphylococcal Infectionsmedicine.disease3. Good healthCell biologyHistoneLiverNeutrophil InfiltrationStaphylococcus aureusNeutrophil elastaseImmunologybiology.proteinLeukocyte ElastaseInfiltration (medical)
researchProduct

Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

2017

Objectives: To compare the concordance of ceftaroline MIC values by reference broth microdilution (BMD) and Etest (bioMérieux, France) for MSSA and MRSA isolates obtained from PREMIUM (D372SL00001), a European multicentre study. Methods: Ceftaroline MICs were determined by reference BMD and by Etest for 1242 MSSA and MRSA isolates collected between February and May 2012 from adult patients with community-acquired pneumonia or complicated skin and soft tissue infections; tests were performed across six European laboratories. Selected isolates with ceftaroline resistance in broth (MIC >1 mg/L) were retested in three central laboratories to confirm their behaviour. Results: Overall concordance…

Male0301 basic medicineCephalosporinPharmacologiemedicine.disease_causeCommunity-acquired pneumoniaPneumonia StaphylococcalCommunity-Acquired InfectionPharmacology (medical)Pathologie maladies infectieusesAged 80 and overMicrobial Sensitivity TestBroth microdilutionCeftalorine; Staphylococcus aureus; PREMIUM STUDY GROUPCeftalorineMiddle AgedAnti-Bacterial AgentsCommunity-Acquired InfectionsEuropeInfectious DiseasesStaphylococcus aureusStaphylococcus aureuStaphylococcal Skin InfectionsFemaleHumanAdultMicrobiology (medical)medicine.medical_specialtyStaphylococcus aureusAdolescentmedicine.drug_classCephalosporin030106 microbiologyPREMIUM STUDY GROUPMicrobial Sensitivity TestsStaphylococcal Skin InfectionMicrobiologyYoung Adult03 medical and health sciencesInternal medicineAnti-Bacterial AgentmedicineHumansEtestAgedPharmacologyAdult patientsbusiness.industrybiochemical phenomena metabolism and nutritionmedicine.diseasebacterial infections and mycosesMethicillin-resistant Staphylococcus aureusCephalosporinsMethicillin Susceptible Staphylococcus Aureusbusiness
researchProduct

Occurrence of methicillin-resistant Staphylococcus aureus in the nasal cavity of healthy volunteer students of the University of Valencia (Spain).

2014

Microbiology (medical)Nasal cavityAdultMaleMethicillin-Resistant Staphylococcus aureusmedicine.medical_specialtyUniversitiesDentistrymedicine.disease_causeYoung AdultImmunology and Microbiology(all)Internal medicineHealthy volunteersmedicinePrevalenceImmunology and AllergyAnimalsHumansStudentsGeneral Immunology and Microbiologybusiness.industryGeneral MedicineStaphylococcal InfectionsMethicillin-resistant Staphylococcus aureusHealthy VolunteersInfectious Diseasesmedicine.anatomical_structureSpainCarrier StateFemaleNasal CavitybusinessJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
researchProduct

Novel strategies in the war against antibiotic resistance

2021

The global threat of antibiotic resistance is steadily growing. Antibiotic resistancemay involve any class of antibiotic, including second- and third-line agents that have been considered to date the last-resort drugs to counteract common infections. We may lose our capability to keep under control many common bacterial infections [1]. Despite this, in the past decade significant research efforts have been made to develop new antibacterial strategies able to treat multidrug-resistant infections; however, no new therapeutic approach has yet reached the clinic [2,3]. In order to identify new valuable antimicrobial drugs, it is important to consider the main bacterial resistance mechanisms in …

Methicillin-Resistant Staphylococcus aureusPharmacologyVirulencebiologyChemistryEscherichia coli ProteinsProtein Disulfide-IsomerasesBiofilmDrug Resistance MicrobialAnti-Bacterial AgentsMicrobiologyDsbAAntibiotic resistanceBiofilmsDrug DiscoveryEscherichia colibiology.proteinMolecular Medicineantibiotic resistance antivirulence strategy biofilm DsbA MRSA
researchProduct

Staphylococcal cassette chromosome mec typing and mecA sequencing in methicillin-resistant staphylococci from Algeria: a highly diversified element w…

2016

Genetic mechanisms of methicillin resistance are still relevant in staphylococci. The aims of this study are to assess the possible exchanges of staphylococcal cassette chromosome mec (SCCmec) among isolates of methicillin-resistant staphylococci (MRS) and to check for known or new mutations in mecA DNA. A total of 35 MRS non-repetitive isolates were recovered, including 20 Staphylococcus haemolyticus, 7 Staphylococcus aureus, 4 Staphylococcus sciuri, 2 Staphylococcus saprophyticus and 1 isolate each of Staphylococcus xylosus and Staphylococcus lentus. Only 16 of the 35 strains were assigned to known SCCmec types: 7 SCCmec VII, 6 SCCmec IV and 3 SCCmec III, with possible horizontal transfer…

0301 basic medicineMicrobiology (medical)Methicillin-Resistant Staphylococcus aureusSettore MED/07 - Microbiologia E Microbiologia ClinicaStaphylococcus030106 microbiologyMicrobial Sensitivity TestsBiologymedicine.disease_causebeta-LactamsMicrobiologyBacterial geneticsMicrobiology03 medical and health sciencesBacterial ProteinsmedicineMissense mutationHumansPenicillin-Binding ProteinsTypingmecAGeneticsMutationSCCmecChromosomeGeneral Medicinerespiratory systembiochemical phenomena metabolism and nutritionChromosomes BacterialStaphylococcal Infectionsbacterial infections and mycosesStaphylococcus aureusStaphylococcus aureus; Methicillin Resistance; mecAAlgeriaHorizontal gene transferMutationStaphylococcus aureuMethicillin ResistanceJournal of medical microbiology
researchProduct

No effect of vancomycin MIC ≥ 1.5 mg/L on treatment outcome in methicillin-susceptible Staphylococcus aureus bacteraemia

2018

International audience; The vancomycin minimum inhibitory concentration (MIC) has been shown to affect the outcome of methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia. In this study, the outcomes of patients with MSSA bacteraemia with a vancomycin MIC ≥ 1.5 mg/L were assessed. A prospective cohort of patients with MSSA bacteraemia in two tertiary-care hospitals was collected. The vancomycin MIC was determined by Etest. Staphylococcus aureus strains were categorised as low (<1.5 mg/L) or high (≥1.5 mg/L) vancomycin MIC. First- and second-line treatments were recorded and classified as optimal, appropriate and inappropriate. The primary endpoint was 30-day mortality. A total o…

0301 basic medicineMicrobiology (medical)MaleMethicillin-Resistant Staphylococcus aureusmedicine.medical_specialtyStaphylococcus aureusmedicine.drug_classmedicine.medical_treatment030106 microbiologyAntibioticsBacteremiaMicrobial Sensitivity Testsmedicine.disease_cause03 medical and health sciencesMinimum inhibitory concentrationVancomycin[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyInternal medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologymedicineHumansPharmacology (medical)Prospective StudiesMortalityProspective cohort studyEtestDialysisAgedAged 80 and overMinimum inhibitory concentrationbusiness.industryGeneral MedicineMiddle AgedStaphylococcal Infectionsbiochemical phenomena metabolism and nutritionbacterial infections and mycoses3. Good healthAnti-Bacterial Agents[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyInfectious DiseasesStaphylococcus aureusCatheter-Related InfectionsVancomycinBacteraemiaFemaleMethicillin Susceptible Staphylococcus Aureusbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct

Use of platelet concentrate gel in second-intention wound healing: a case report.

2021

Abstract Background Wound healing is a complex and dynamic process. Healing of acute and chronic wounds can be impaired by patient factors (that is, comorbidities) and/or wound factors (that is, infection). Regenerative medicine products, such as autologous/homologous platelet-rich plasma gel, may speed up the healing process. Autologous/homologous platelet-rich plasma is an advanced wound therapy used for hard-to-heal acute and chronic wounds. The cytokines and growth factors contained in platelet-rich plasma play a crucial role in the healing process. Case presentation A 61-year-old Caucasian male patient, suffering from mental retardation following meningitis, with a transplanted kidney …

MaleMethicillin-Resistant Staphylococcus aureusmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentFistulaArteriovenous fistulalcsh:MedicineCase ReportIntention030204 cardiovascular system & hematology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAntisepticSurgical oncologymedicineHumansWound Healingintegumentary systembusiness.industryPlatelet-Rich Plasmalcsh:RGranulation tissueGeneral MedicineMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureAmputationRegenerative medicineQuality of LifeSkin flapSurgeryWound healingbusinessMeningitisJournal of medical case reports
researchProduct

Healthcare-Associated Pneumonia and Multidrug Resistant Bacteria: Do We Have a Convincing Answer?

2014

Methicillin-Resistant Staphylococcus aureusMicrobiology (medical)medicine.medical_specialtyBacteriabusiness.industryMedicine (all)Drug ResistanceBacterialPneumonia Ventilator-AssociatedBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)Pneumoniamedicine.diseasePneumoniaVentilator-AssociatedMultidrug resistant bacteriaInfectious DiseasesHealthcare associatedEnterobacteriaceaeDrug Resistance BacterialPseudomonas aeruginosamedicineBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance; Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)HumansIntensive care medicinebusiness
researchProduct